| Russell Darren Goldstein, MD | |
|
5200 Hahns Peak Dr, Loveland, CO 80538-8852 | |
| (970) 962-4900 | |
| Not Available |
| Full Name | Russell Darren Goldstein |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 5200 Hahns Peak Dr, Loveland, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902327745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 7983 (Nebraska) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR0067319 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Russell Darren Goldstein, MD 2403 Copper Crest Ln, Fort Collins, CO 80528-2400 Ph: (303) 709-0638 | Russell Darren Goldstein, MD 5200 Hahns Peak Dr, Loveland, CO 80538-8852 Ph: (970) 962-4900 |
News Archive
Axion HealthTM (www.axionhealth.com), a workforce health protection, emergency preparedness and response provider, today announced that it will partner with Comprehensive Health Services, Inc. (www.chsmedical.com), the industry's largest independent provider of onsite health centers, nationwide exam programs and rapid response medical readiness teams for workforce health to deliver its ReadySetTM Program for Workforce Emergency Preparedness and Response; including the ReadySet Pandemic Program for prevention, protection and response to pandemic health threats.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.
Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment.
› Verified 3 days ago
Aatif Mansoor, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2000 Boise Ave, Loveland, CO 80538 Phone: 970-820-4640 | |
Srinivas Bandi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2923 Ginnala Dr, Loveland, CO 80538 Phone: 970-669-6660 Fax: 970-663-0721 | |
Eric J Straumanis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1762 Hoffman Dr, Loveland, CO 80538 Phone: 970-663-3030 Fax: 970-663-3041 | |
Dr. Sheri J Friedman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2695 Rocky Mountain Ave, Suite 200, Loveland, CO 80538 Phone: 970-667-7664 Fax: 970-622-9843 | |
Sonya S Wakil, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 221 E 29th St Ste 101, Loveland, CO 80538 Phone: 970-494-4200 | |
Jeffrey B Warren, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1615 Foxtrail Dr Ste 230, Loveland, CO 80538 Phone: 970-820-0470 Fax: 970-315-0030 | |
Dr. Lawrence A Meredith, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2695 Rocky Mountain Ave, Suite 200, Loveland, CO 80538 Phone: 970-667-7664 Fax: 970-622-9843 |